These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30777646)

  • 1. Perspectives on privacy in the pharmacy: The views of opioid substitution treatment clients.
    Le PP; Braunack-Mayer A
    Res Social Adm Pharm; 2019 Aug; 15(8):1021-1026. PubMed ID: 30777646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing pharmacy services in opioid substitution treatment.
    Chaar BB; Wang H; Day CA; Hanrahan JR; Winstock AR; Fois R
    Drug Alcohol Rev; 2013 Jul; 32(4):426-34. PubMed ID: 23442133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senior nurses' perspectives on the transfer of opioid substitution treatment clients from clinics to community pharmacy.
    Bui J; Day C; Hanrahan J; Winstock A; Chaar B
    Drug Alcohol Rev; 2015 Sep; 34(5):495-498. PubMed ID: 25302986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia.
    Winstock AR; Lea T; Sheridan J
    Addiction; 2010 Feb; 105(2):335-42. PubMed ID: 20078490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumer satisfaction with opioid treatment services at community pharmacies in Australia.
    Lea T; Sheridan J; Winstock A
    Pharm World Sci; 2008 Dec; 30(6):940-6. PubMed ID: 18850299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of community pharmacy space to enhance privacy: a qualitative study.
    Hattingh HL; Emmerton L; Ng Cheong Tin P; Green C
    Health Expect; 2016 Oct; 19(5):1098-110. PubMed ID: 26332335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial.
    Radley A; de Bruin M; Inglis SK; Donnan PT; Dillon JF
    BMJ Open; 2018 Dec; 8(12):e021443. PubMed ID: 30552244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lived experience of Australian opioid replacement therapy recipients in a community-based program in regional Victoria.
    Patil Vishwanath T; Cash P; Cant R; Mummery J; Penney W
    Drug Alcohol Rev; 2019 Sep; 38(6):656-663. PubMed ID: 31577061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Privacy and confidentiality: perspectives of mental health consumers and carers in pharmacy settings.
    Hattingh HL; Knox K; Fejzic J; McConnell D; Fowler JL; Mey A; Kelly F; Wheeler AJ
    Int J Pharm Pract; 2015 Feb; 23(1):52-60. PubMed ID: 24761999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of online training for the provision of opioid substitution treatment by community pharmacists in New Zealand.
    Walters C; Raymont A; Galea S; Wheeler A
    Drug Alcohol Rev; 2012 Nov; 31(7):903-10. PubMed ID: 22519647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
    Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
    Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australian mental health consumers and carers expect more health management information from community pharmacy.
    Fejzic J; Knox K; Hattingh HL; Mey A; McConnell D; Wheeler AJ
    Int J Pharm Pract; 2017 Dec; 25(6):454-462. PubMed ID: 28303618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies.
    Gauthier G; Eibl JK; Marsh DC
    Drug Alcohol Depend; 2018 Oct; 191():1-5. PubMed ID: 30064001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuation of opioid replacement program delivery in the aftermath of cyclones in Queensland, Australia: A qualitative exploration of the perspectives of pharmacists and opioid replacement therapy staff.
    O'Dwyer N; Cliffe H; Watson KE; McCourt E; Singleton JA
    Res Social Adm Pharm; 2020 Aug; 16(8):1081-1086. PubMed ID: 31753692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' role in preventing opioid substitution therapy-related deaths: a qualitative investigation into current UK practice.
    Yadav R; Taylor D; Taylor G; Scott J
    Int J Clin Pharm; 2019 Apr; 41(2):470-477. PubMed ID: 30771145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
    Treloar C; Rance J; Grebely J; Dore GJ
    Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative pharmacist prescribing within the opioid substitution treatment program in South Australia: Patient and pharmacist views.
    Le PP; Braunack-Mayer A; Laurence C
    Res Social Adm Pharm; 2018 Feb; 14(2):187-195. PubMed ID: 28325527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.